NEW YORK, April 14, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
Macular Degeneration Therapy Area Pipeline Report
The Macular Degeneration Therapy Area Pipeline Report contains
detailed information on the macular degeneration drug pipeline.
This report provides insight into the pipeline status of macular
degeneration drugs by company and by stage as well as a summary of
the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics’ Therapy Area Pipeline Report
provides the user with real detail on drug pipelines, by company
and by stage, for each specific therapy area. The latest news, by
company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline
projects, each report also contains extensive information in
tabular format on a company’s full product pipeline and products by
phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include
detailed product descriptions, information on partnering activity
plus clinical trial intelligence. Each Therapy Area Pipeline Report
also provides detail on the top 20 companies with products in the
early stage of development and the top 20 companies with products
in the late stage of development. Finally, each report also
provides a comparison with other major indications in the disease
hub based on Marketed Products vs. Pipeline Products.
• Understand a c